National Institutes of Health logo
National Institutes of Health

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

Funds better drug dosing and safer medicines for pregnant women, lactating women, infants, children and adolescents.

Most drugs are tested and dosed on adults who are not pregnant, not breastfeeding and not children — so dosing for anyone outside that group is often a guess extrapolated from someone else's data. This notice funds closing that gap.

Four kinds of work qualify, and any one of them is enough: precision-medicine tools, models or technologies for this population; new therapeutics, or better use of dr

Translational and clinical research advancing precision therapeutics for pregnant women, lactating women, infants, children and adolescents — developing novel drugs or improving the use of existing ones, advancing precision-medicine tools, improving patient-provider communication on drug safety, and scaling evidence-based interventions.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.9 Jul 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: PAR-28-059Source: www.grants.gov